أعرض في EDS

Efficacy And Safety Of Bradykinin B2 Receptor Inhibition With Oral PHVS416 In Treating Hereditary Angioedema Attacks: Results Of RAPIDe-1 Phase 2 Trial

التفاصيل البيبلوغرافية
العنوان:	Efficacy And Safety Of Bradykinin B2 Receptor Inhibition With Oral PHVS416 In Treating Hereditary Angioedema Attacks: Results Of RAPIDe-1 Phase 2 Trial
المؤلفون:	Marcus Maurer, John Anderson, Emel Aygören-Pürsün, Laurence Bouillet, María Luisa Baeza, Hugo Chapdelaine, Danny Cohn, Aurélie Du-Thanh, Olivier Fain, Henriette Farkas, Jens Greve, Mar Guilarte, David Hagin, Roman Hakl, Joshua Jacobs, Aharon Kessell, Sorena Kiani-Alikhan, Pavlína Králíčková, Huamin Li, Ramon Lleonart Bellfill, Markus Magerl, Michael Manning, Avner Reshef, Bruce Ritchie, Giuseppe Spadaro, Maria Staevska, Petra Staubach, Marcin Stobiecki, Gordon Sussman, Michael Tarzi, Anna Valerieva, William Yang, Marie-Helene Jouvin, Rafael Crabbé, Simone van Leeuwen, Huaihou Chen, Li Zhu, Jochen Knolle, Anne Lesage, Peng Lu, Marc Riedl
المصدر:	Journal of Allergy and Clinical Immunology. 151:AB134
بيانات النشر:	Elsevier BV, 2023.
سنة النشر:	2023
مصطلحات موضوعية:	Immunology, Immunology and Allergy
تدمد:	0091-6749
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=doi_________::a6c32082625d2ce19b7bcabc320b5948Test https://doi.org/10.1016/j.jaci.2022.12.419Test
حقوق:	CLOSED
رقم الانضمام:	edsair.doi...........a6c32082625d2ce19b7bcabc320b5948
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	00916749